David Burt

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study

David Gordon, Edward T. Hellriegel, Heidi R. Hope et al. · Clinical Pharmacology Advances and Applications · 2021 · 25 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Statistical Assessment of QT/QTc Prolongation Based on Maximum of Correlated Normal Random Variables

Bin Cheng, Shein‐Chung Chow, David Burt et al. · Journal of Biopharmaceutical Statistics · 2008 · 17 citations

Medicine, Biostatistics, Pharmacology +13

Selective Inhibition of the <scp>MK2</scp> Pathway: Data From a Phase <scp>IIa</scp> Randomized Clinical Trial in Rheumatoid Arthritis

David Gordon, Alan Kivitz, Atul Singhal et al. · ACR Open Rheumatology · 2023 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16